CALU expression based on
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison | Statistical significance |
Normal-vs-Primary | 4.76039996311073E-09 |
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
5.82109999999192E-05 |
Normal-vs-Stage2 |
2.647900E-04 |
Normal-vs-Stage3 |
N/A |
Normal-vs-Stage4 |
1.185000E-03 |
Stage1-vs-Stage2 |
5.895700E-02 |
Stage1-vs-Stage3 |
N/A |
Stage1-vs-Stage4 |
8.292800E-01 |
Stage2-vs-Stage3 |
N/A |
Stage2-vs-Stage4 |
6.756000E-02 |
Stage3-vs-Stage4 |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.66850000038465E-07 |
Normal-vs-AfricanAmerican |
1.96359994930617E-09 |
Normal-vs-Asian |
4.988300E-02 |
Caucasian-vs-AfricanAmerican |
3.036200E-01 |
Caucasian-vs-Asian |
9.000800E-01 |
AfricanAmerican-vs-Asian |
5.324600E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
2.588100E-04 |
Normal-vs-Female |
5.0891000002995E-07 |
Male-vs-Female |
1.717990E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient BMI information is not available for 1 sample.
Descriptions |
Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Normal_Weight |
5.584500E-03 |
Normal-vs-Extreme_Weight |
1.63900999999855E-05 |
Normal-vs-Obese |
8.862000E-03 |
Normal-vs-Extreme_Obese |
N/A |
Normal_Weight-vs-Extreme_Weight |
7.597000E-01 |
Normal_Weight-vs-Obese |
9.789900E-02 |
Normal_Weight-vs-Extreme_Obese |
N/A |
Extreme_Weight-vs-Obese |
1.403390E-01 |
Extreme_Weight-vs-Extreme_Obese |
N/A |
Obese-vs-Extreme_Obese |
N/A |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.687780E-01 |
Normal-vs-Age(41-60Yrs) |
9.449500E-04 |
Normal-vs-Age(61-80Yrs) |
4.45850000000414E-05 |
Normal-vs-Age(81-100Yrs) |
2.980800E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
6.777800E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.554600E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.527380E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.681400E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.920200E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.786600E-01 |
|
|
CHOL : Cholangiocarcinoma
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
N/A |
Normal-vs-Grade 2 |
9.852600E-01 |
Normal-vs-Grade 3 |
5.955000E-01 |
Normal-vs-Grade 4 |
1.000000E+00 |
Grade 1-vs-Grade 2 |
N/A |
Grade 1-vs-Grade 3 |
N/A |
Grade 1-vs-Grade 4 |
N/A |
Grade 2-vs-Grade 3 |
1.614550E-01 |
Grade 2-vs-Grade 4 |
9.852600E-01 |
Grade 3-vs-Grade 4 |
5.955000E-01 |
|
|
CHOL : Cholangiocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 5 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
9.33639999978197E-07 |
Normal-vs-N1 |
2.833400E-04 |
N0-vs-N1 |
1.793410E-01 |
|
|